Masimo in Pivotal Point Check: Patient Monitoring Specialist Significantly Exceeds Revenue and Earnings Expectations in Q4 - Stock Ends Consolidation After Strategic Realignment!
Reading Time: 2 minutes
In Q4, Masimo significantly exceeded the analyst consensus of $1.42 with an adjusted earnings per share of $1.80. The medical technology manufacturer is currently realigning its strategies and refocusing on its core healthcare business after the acquisition of Sound United. For 2025, the company expects earnings per share between $5.10 and $5.40, which is well above the consensus estimate of $4.65. The medical technology manufacturer released its Q4 results on February 25, 2025, surpassing analysts' expectations. The company is a leader...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
